## Clinical Presentation Analysis **Key Point:** The classic triad of progressive neurodegeneration (onset ~6 months), hepatosplenomegaly, cherry-red spot on macula, and foamy macrophages on bone marrow smear is pathognomonic for **Niemann-Pick disease Type A** (sphingomyelinase deficiency). ### Diagnostic Features — Comparison Table | Feature | Niemann-Pick Type A | GM1 Gangliosidosis | Gaucher Disease | Metachromatic Leukodystrophy | |---------|--------------------|--------------------|-----------------|------------------------------| | **Cherry-red spot** | Yes (cardinal) | Yes (infantile) | No | No | | **Hepatosplenomegaly** | Marked | Marked | Marked | Absent | | **Neurodegeneration onset** | 3–6 months | 6 months | Variable | 12–18 months | | **Foamy macrophages (BM)** | Yes (sphingomyelin-laden) | Yes | Yes (Gaucher cells) | No | | **Enzyme deficiency** | Sphingomyelinase | β-galactosidase | Glucocerebrosidase | Arylsulfatase A | | **Acid phosphatase** | Elevated | Elevated | Markedly elevated | Normal | | **Prognosis** | Death by age 3 | Death by age 2 | Variable | Variable | ### Why Niemann-Pick Type A is the Best Answer Niemann-Pick disease Type A results from deficiency of **acid sphingomyelinase (SMPD1 gene)**, leading to accumulation of sphingomyelin in neurons, hepatocytes, and macrophages. The classic presentation includes: 1. **Cherry-red spot** — sphingomyelin accumulation in retinal ganglion cells creates the characteristic macular appearance; the fovea (lacking ganglion cells) appears red against the pale surrounding retina. 2. **Hepatosplenomegaly** — sphingomyelin-laden macrophages (foam cells) engorge the liver and spleen. 3. **Foamy macrophages on bone marrow smear** — the hallmark histological finding; macrophages are distended with sphingomyelin. 4. **Progressive neurodegeneration from ~6 months** — rapid psychomotor regression leading to death typically by age 2–3 years. 5. **Elevated acid phosphatase** — a non-specific lysosomal marker elevated in many storage disorders, including Niemann-Pick. ### Why the Other Options Are Less Likely - **GM1 Gangliosidosis (B):** Also presents with cherry-red spot and hepatosplenomegaly, but the **defining storage material is GM1 ganglioside** (β-galactosidase deficiency). While the clinical overlap is real, the **foamy macrophage** appearance on bone marrow is more classically and prominently described in Niemann-Pick (sphingomyelin-laden foam cells). In standard NEET PG/NBE teaching, the triad of cherry-red spot + hepatosplenomegaly + foamy macrophages is the textbook presentation of Niemann-Pick Type A. - **Gaucher disease (A):** No cherry-red spot; bone marrow shows "crinkled tissue paper" Gaucher cells (glucocerebroside-laden), not foamy macrophages. - **Metachromatic leukodystrophy (D):** No cherry-red spot, no hepatosplenomegaly; primarily a white matter disease with metachromatic deposits in peripheral nerves. **Clinical Pearl:** In NBE/NEET PG examinations, the combination of **cherry-red spot + hepatosplenomegaly + foamy macrophages** is the classic teaching triad for **Niemann-Pick disease Type A**. GM1 gangliosidosis shares some features but is distinguished by coarse facial features, skeletal dysplasia (dysostosis multiplex), and the specific enzyme defect (β-galactosidase). **High-Yield Mnemonic — Cherry-Red Spot disorders:** - **N**iemann-Pick (Type A) - **T**ay-Sachs / **G**M1 gangliosidosis - **S**ialidosis - **C**entral retinal artery occlusion (non-storage) [cite: Robbins & Cotran Pathologic Basis of Disease, 10e, Ch 5; KD Tripathi Essentials of Medical Pharmacology; Harper's Illustrated Biochemistry]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.